Skip to main content

Table 2 Comparison between the studied groups according to clinical data

From: Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients

Clinical data

Group (I) HCC n = 25

Group (II) cirrhosis n = 25

P value

n

%

n

%

Jaundice

13

52

3

12

0.03*

Clubbing

20

80

9

36

< 0.001*

Ecchymosis

19

76

10

40

0.02*

Hepatomegaly

2

8

6

24

0.5

Hard liver

10

40

0

0

0.004*

Splenomegaly

18

72

20

80

0.13

Abdominal pain

15

60

10

40

0.903

Easy fatigability

20

80

16

64

0.65

Loss of weight

22

88

20

80

0.865

  1. *Significant